Ready to Scale, Ready to Fund - Session 4: Funding beyond VCs
Ready to Scale, Ready to Fund is a four-session program for founders and teams building medical biotech, medtech and digital health companies. The series brings together practical pitch coaching, go-to-market and IP strategy, venture capital insights, corporate venturing and alternative financing options.
Across the four sessions, participants will strengthen how they present their company, connect scientific or technological innovation to a credible market pathway, and make more informed funding choices. The program is designed around the different development journeys of biotech and healthtech companies, while focusing on the questions investors and strategic partners consistently ask.
Session 4: Funding beyond VCs
Not every milestone should be financed in the same way. The final session looks beyond traditional venture capital and helps participants consider how grants, subsidies, angels, family offices and commercial collaborations can complement equity financing. The goal is to build a funding path aligned with the company’s stage, capital intensity, evidence needs and growth plan.
Program
- Designing a blended funding strategy
Matching funding sources to milestones, risk, timing and company stage. - Angel investors and family offices
How non-VC investors operate, what they look for in founder teams and the terms they may expect. - Break and exchange
Questions, peer learning and practical examples. - Public grants and subsidies
Regional, national and European opportunities and how non-dilutive funding can support development. - Commercial collaborations as a funding lever
Paid pilots, sponsored research, co-development, licensing and customer-funded development. - Putting the funding mix together
Final discussion and actions for a more resilient financing roadmap.
Key topics
- Overview of non-VC financing options
- How to combine dilutive and non-dilutive funding
- What angels and family offices may seek in the team, opportunity and deal
- Using grants and subsidies to reach technical, clinical, regulatory or commercial milestones
- Structuring collaborations without losing sight of long-term strategic value
- Adapting the financing mix to the needs of biotech, medtech and digital health companies
Ready to join?
The program is open to all Biovia members and HealthTech Investor Summit participants. *Hybrid access is available for participants based outside Belgium.
We encourage you to follow the full series to build progressively from pitch to market strategy and financing.
More info on the other session from the Ready to Scale, Ready to Fund series:
- Session 1: What investors really want to hear (27 October 2026, Online)
- Session 2: Master your go-to-market and IP strategy (05 November 2026, Diegem - Hybrid*)
- Session 3: Corporate venturing and venture capital deep dive (17 November 2026, Antwerp - Hybrid*)